Filter
2319
Filtered Results: 2319
Text search:
chemicals
Featured
Recommendations
280
New Publications
607
Language
Document type
No document type
1165
Studies & Reports
368
Guidelines
364
Manuals
184
Strategic & Response Plan
87
Fact sheets
54
Training Material
50
Infographics
13
Situation Updates
11
Resource Platforms
11
Brochures
9
Online Courses
2
Videos
1
Countries / Regions
India
140
Global
98
Kenya
80
Ethiopia
50
Syria
46
Sierra Leone
40
South Africa
40
Ghana
39
Liberia
37
Nepal
37
Nigeria
36
Uganda
34
Ukraine
34
Latin America and the Carribbean
33
Western and Central Europe
31
Tanzania
30
Bangladesh
28
Africa
26
Myanmar / Burma
25
Philippines
24
Rwanda
22
Zimbabwe
20
Malawi
19
Namibia
18
Zambia
16
USA
15
Eastern Europe and Central Asia
13
Indonesia
12
South–East Asia Region
12
Eswatini/ Swaziland
11
Russia
11
Guinea
9
Senegal
9
Congo, Democratic Republic of
8
Haiti
8
Brazil
8
Lesotho
7
Middle East and North Africa
7
Cameroon
6
Iraq
6
Germany
6
Sudan
6
Botswana
6
Yemen
6
Asia
6
Burkina Faso
5
South Sudan
5
Afghanistan
5
Mozambique
5
Madagascar
5
Western Pacific Region
5
Eastern Europe
5
Mali
4
Cambodia
4
Thailand
4
West and Central Africa
4
Vietnam
4
Somalia
3
Pakistan
3
Jordan
3
Lebanon
3
North Macedonia
3
Tajikistan
3
Iran
3
Côte d’Ivoire / Ivory Coast
2
Saudi Arabia
2
Niger
2
Chad
2
China
2
Peru
2
Colombia
2
East and Southern Africa
2
Paraguay
2
Bhutan
2
Venezuela
2
Albania
2
Laos
2
Timor Leste/ East Timor
2
Moldova
2
Kazakhstan
2
Georgia
2
Gabon
2
Morocco
1
Egypt
1
Gambia
1
Mauritania
1
Singapore
1
Papua New Guinea
1
Benin
1
Central African Republic
1
Argentina
1
Serbia
1
Hungary
1
Croatia
1
Ecuador
1
El Salvador
1
Bolivia
1
Greece
1
Libya
1
Sri Lanka
1
Fiji
1
Poland
1
Palestine
1
Djibouti
1
Armenia
1
Mongolia
1
Southern Africa
1
Canada
1
Qatar
1
Bulgaria
1
Romania
1
Lithuania
1
Slovakia
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Turkmenistan
1
Maldives
1
Mauritius
1
Tunisia
1
United Kingdom
1
Spain
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
805
Key Resources
216
Clinical Guidelines
170
Public Health
146
Pharmacy & Technologies
60
Women & Child Health
59
Capacity Building
54
Toolboxes
Planetary Health
192
Mental Health
156
COVID-19
151
Pharmacy
125
AMR
120
Rapid Response
119
Conflict
99
Specific Hazards
84
Caregiver
72
Ebola
65
Natural Hazards
61
NTDs
59
TB
58
NCDs
55
Global Health Education
48
HIV
45
Refugee
28
Cholera
26
Zika
26
Disability
23
Social Ethics
7
Polio
5
Health Financing Toolbox
5
Typhoon
1
The WHO Global Antimicrobial Resistance and Use Surveillance System (GLASS) was launched in 2015 to foster AMR surveillance and inform strategies to contain AMR. The system started with surveillance of AMR in bacteria causing common human infections and has expanded its scope to include surveillance...
Atlas of African Health Statistics 2022: Health situation analysis of the WHO African Region
Since 2019, we have been implementing Phase 2 of the regional Transformation Agenda, which informs and aligns with the global WHO Transformation, to ensure WHO is accountable, driven by re- sults and provid...
This manual provides a framework for morbidity management and disability prevention of patients affected by NIDs and gives specific guidance for the proper care of patients suffering from chronic conditions caused by lymphatic filariasis, leprosy, trachoma, and Chagas disease. It is intended to be u...
The Arab region in the Middle East and North Africa (MENA) represents a substantial area of the terrestrial landmass encompassing several countries and ecosystems. This area is generally drier and warmer compared to the rest of the world and has extreme resource limitations that are highly vulnerabl...
Trachoma is the leading infectious cause of blindness (2). It is characterized by repeated
conjunctival infection with particular strains of Chlamydia trachomatis. This scars the conjunctivae and,
in some cases, leads to trichiasis with or without entropion. The abrasive action of eyelashes can
d...
Trachoma causes more vision loss and blindness than any other infection in the world. This disease is caused by Chlamydia trachomatis bacteria. Other variants or strains of these bacteria can cause a sexually transmitted infection (chlamydia) and disease in lymph nodes.
This is photomicrograph ...
This strategy defines the World Health Organization (WHO) vision and framework for supporting Member States to accelerate the development, implementation and monitoring of their National Action Plan for Health Security (NAPHS) from 2022 to 2026. The National Action Plan for Health Security (NAPHS) ...
Pharmaceutical News
Evaluation of Saccharide Content of the WHO 2nd International Standard for Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP) by HPAECPAD Analysis Following Acid Hydrolysis
Consultation Documents
Lamivudine and tenofovir disoproxil fumarate tablets (lami...
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,...
April 2022 Volume 35 Issue 2 e00152-21
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where t...
In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs [2]. The Target 3.3 of the United Nations Sustainable Development Goals (UN/SDG) aims at ending the e...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
This guideline for the prevention and control of chikungunya fever
(CF) is intended for use by all peripheral health workers in the Region and
is based on the strategy outlined above. This document will focus mainly
on preventing, predicting and detecting outbreaks, and after detection,
investig...
Epidemiological Update
Dengue
7 February 2020
Situation summary
In the Region of the Americas, between epidemiological week (EW) 1 and EW 521 of 2019, a total of 3,139,335 cases of dengue have been reported (321.58 cases per 100,000 population), including 1,538 deaths. Of the total cases, 1,367,...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
Full Perscribing information on Fexinidazole Tablet for oral use
INDICATIONS AND USAGE
Fexinidazole Tablets are indicated for the treatment of both the first-stage (hemolymphatic) and second-stage (meningoencephalitic) human African trypanosomiasis (HAT) due to Trypanosoma brucei gambiense in pati...
FIND and Standard Diagnostics (SD) have developed a lateral flow rapid diagnostic test (RDT) to screen for
T.b. gambiense HAT that is cheap and easy to use. The tests are packed individually and are stable at 40°C for
up to 25 months; they are performed on fresh blood obtained from a finger prick...
This handbook is intended primarily for front-line health care providers who are likely to see children (among other clients) in their day-to-day practice. These may include general practitioners, nurses, midwives, gynaecologists,
paediatricians, mental health professionals, first responders and st...
Sleeping sickness is controlled by case detection and treatment but this often only reaches less than 75% of the population. Vector control is capable of completely interrupting HAT transmission but is not used because of expense. We conducted a full scale field trial of a refined vector control tec...
This brochure presents a summary of the situation of health systems and services in the Americas as they progress toward the achievement of universal access to health and universal health coverage (universal health). The information provided presents an overview of the situation before the COVID-19 ...
